Monte Rosa Therapeutics (GLUE) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

GLUE is expected to report earnings to fall 162.14% to 18 cents per share on March 13

Monte Rosa Therapeutics GLUE Stock Earnings Reports

Q4'24

Est.

$0.18

Q3'24

Beat

by $0.18

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.06

Q4'23

Missed

by $0.19

The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -46 cents. With 1.79M shares outstanding, the current market capitalization sits at 431.90M.

View a ticker or compare two or three

Compare

GLUE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GLUE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GLUE (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

321 Harrison Avenue

Phone

+1 617 949-2643

Employees

133

Web

https://www.monterosatx.com